Search

everythinglearnresearchcommunity

for

Search:↓

The topical treatment with caffeine and Procapil 3% improved male pattern hair loss and was well tolerated after 12 weeks.

Mitochondrial problems in diabetic nerve damage might cause pain by lowering the production of certain nerve-related steroids.

Diabetic neuropathy in mice is linked to poor mitochondria function and lower brain hormone production.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Baicalin may help reduce excessive male hormone levels in PCOS.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Physcion may help treat hair loss by blocking an enzyme linked to baldness.

Bee venom helps hair grow and may work better than some common treatments.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Heparan sulfate is important for hair growth, preventing new hair formation in mature skin, and controlling oil gland development.

Dutasteride improved hair density and thickness in men not helped by finasteride, with minimal side effects.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Low-dose UVB light improves hair growth effects of certain stem cells by increasing reactive oxygen species.

Hdac1 and Hdac2 help maintain and protect the cells that control hair growth.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Compounds from certain trees used by First Nations people show potential for treating skin conditions and promoting hair growth, but more research is needed to confirm their safety and effectiveness.

The combination treatment showed a higher response rate but no significant survival benefits.

DPK-060 in poloxamer gel effectively treats skin infections, but nanocarriers don't enhance its efficacy.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Autophagy helps activate hair stem cells and hair growth by changing their energy use to glycolysis.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.